647 related articles for article (PubMed ID: 15726607)
1. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic thrombocytopenia purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy.
Simpson KN; Coughlin CM; Eron J; Bussel JB
Semin Hematol; 1998 Jan; 35(1 Suppl 1):58-64. PubMed ID: 9523750
[TBL] [Abstract][Full Text] [Related]
3. Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura.
Kane I; Ragucci D; Shatat IF; Bussel J; Kalpatthi R
Br J Haematol; 2010 Apr; 149(1):79-83. PubMed ID: 20096011
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
5. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ;
J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411
[TBL] [Abstract][Full Text] [Related]
6. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both.
Gereige RS; Barrios NJ
P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP
Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
[TBL] [Abstract][Full Text] [Related]
8. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
Erduran E; Aslan Y; Gedik Y; Orhan F
Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
[TBL] [Abstract][Full Text] [Related]
9. A comparison of intravenous immunoglobulin (2 g/kg totally) and single doses of anti-D immunoglobulin at 50 μg/kg, 75 μg/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience.
Alioglu B; Ercan S; Tapci AE; Zengin T; Yazarli E; Dallar Y
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):505-9. PubMed ID: 23470649
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.
Ramadan KM; El-Agnaf M
Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495
[TBL] [Abstract][Full Text] [Related]
11. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins.
Rodeghiero F; Schiavotto C; Castaman G; Vespignani M; Ruggeri M; Dini E
Haematologica; 1992; 77(3):248-52. PubMed ID: 1330848
[TBL] [Abstract][Full Text] [Related]
12. Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy?
Bussel JB; Kaufmann CP; Ware RE; Woloski BM
Am J Hematol; 2001 May; 67(1):27-33. PubMed ID: 11279654
[TBL] [Abstract][Full Text] [Related]
13. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
14. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).
Tamminga R; Berchtold W; Bruin M; Buchanan GR; Kühne T
Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971
[TBL] [Abstract][Full Text] [Related]
15. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP).
O'Brien SH; Ritchey AK; Smith KJ
Pediatr Blood Cancer; 2007 Feb; 48(2):173-80. PubMed ID: 16550529
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute immune thrombocytopenic purpura.
Tarantino MD; Goldsmith G
Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
[TBL] [Abstract][Full Text] [Related]
17. A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in Korean children.
Son DW; Jeon IS; Yang SW; Cho SH
J Pediatr Hematol Oncol; 2008 Aug; 30(8):598-601. PubMed ID: 18799936
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effects of and earliest response rate to anti-D treatment in children with chronic idiopathic thrombocytopenic purpura: a pilot study.
Yetgin S; Aytaç S; Olcay L; Tunç B; Ozbek N; Aydinok Y
Turk J Pediatr; 2010; 52(2):126-31. PubMed ID: 20560246
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
Freiberg A; Mauger D
Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
[TBL] [Abstract][Full Text] [Related]
20. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy.
Duru F; Fisgin T; Yarali N; Kara A
Pediatr Hematol Oncol; 2002 Jun; 19(4):219-25. PubMed ID: 12051587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
